Cargando…
The effect of a Clinical Decision Support System on the frequency of dose adjustments of anticancer drugs in case of renal or hepatic dysfunction
INTRODUCTION: Dose adjustments in patients with renal or hepatic dysfunction using anticancer drugs are indicated according to guidelines. However, implementation depends on awareness of prescribing physicians. We implemented a Clinical Decision Support System (CDSS), recommending dose adjustments u...
Autores principales: | Rolvink, José, Gerards, Anne-Loes E, Kater, Arnon P, Swart, Eleonora L, Becker, Matthijs L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288388/ https://www.ncbi.nlm.nih.gov/pubmed/34111993 http://dx.doi.org/10.1177/10781552211019453 |
Ejemplares similares
-
Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application
por: Hendrayana, Tomi, et al.
Publicado: (2017) -
Rare but Serious: Ibrutinib Induced Liver Failure
por: Kleijwegt, Fleur S., et al.
Publicado: (2019) -
The Rate of Antibiotic Dosage Adjustment in Renal Dysfunction
por: Fahimi, Fanak, et al.
Publicado: (2012) -
Clinical Decision Support System with Renal Dose Adjustment Did Not Improve Subsequent Renal and Hepatic Function among Inpatients: The Japan Adverse Drug Event Study
por: Wada, Ryuhei, et al.
Publicado: (2020) -
T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective
por: Peters, Fleur S., et al.
Publicado: (2021)